Generate a tailored SOP for Dr. Minkui Luo. Improve your application with a focused, well-structured draft.
Minkui Luo is a chemical biologist at the Sloan Kettering Institute whose research focuses on developing novel approaches to interface chemistry and biology to annotate the functional roles of epigenetic modulators. His lab challenges the dysregulation of epigenetic processes associated with diseases like cancer. His team designs and synthesizes inhibitors targeting specific epigenetic pathways by creating distinct chemical tools. The Luo Lab emphasizes the development of unprecedented chemical reagents that advance biological discovery and elucidate disease-causing mechanisms at the molecular level. The collaborative nature of the lab fosters innovation in cancer treatment, diversifying the understanding of protein modifications that influence cellular fate patterns.
The program is hosted by the Weill Cornell Graduate School of Medical Sciences in partnership with the Sloan Kettering Institute. GRE scores are optional.